(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -204.08%-1.19M | -83.27%-602.77K | 123.24%3.87M | -62.10%707.4K | 1,177.12%2.35M | 1,558.73%1.14M | -300.57%-328.9K | 178.10%1.73M | 1,699.34%1.87M | 62.04%-218.03K |
Net income from continuing operations | -247.11%-2.52M | -277.67%-1.03M | 1,238.13%601.3K | -214.21%-884.45K | -374.60%-805.87K | 342.20%1.71M | 239.95%578.67K | 98.45%-52.83K | 282.38%774.43K | 152.67%293.47K |
Operating gains losses | ---- | ---- | -109.16%-5.06K | --0 | --0 | --0 | ---5.06K | 168.99%55.25K | 98.01%-1.71K | ---- |
Depreciation and amortization | -67.93%23.88K | 6.93%75.01K | 61.60%294.32K | 63.40%75.01K | 62.75%74.7K | 62.22%74.46K | 57.92%70.15K | 7.38%182.13K | 0.71%45.91K | -5.88%45.9K |
Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --225K | ---- | ---- |
Unrealized gains and losses of investment securities | ---71.43K | --35.71K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Remuneration paid in stock | 8,261.42%625.02K | --4.15K | 118.23%679.77K | -82.53%54.41K | --617.89K | --7.48K | --0 | -37.58%311.49K | 171.98%311.49K | --0 |
Deferred tax | --0 | --0 | 53.40%-69.21K | 57.01%-63.85K | --0 | --0 | ---5.37K | ---148.52K | ---148.52K | --0 |
Other non cashItems | 6.60%261.46K | 2.73%257.94K | 11.18%1.73M | 156.44%984.96K | -37.90%245.31K | -38.23%245.27K | -33.38%251.09K | 16.09%1.55M | 2.20%384.08K | 15.65%395.01K |
Change In working capital | 154.72%490.45K | 104.31%52.55K | 264.19%643.06K | 96.34%541.32K | 319.59%2.22M | -582.19%-896.29K | -880.43%-1.22M | 47.16%-391.66K | 293.72%275.7K | -144.06%-1.01M |
-Change in receivables | 73.44%-192.5K | 121.03%289.04K | 236.23%632.3K | 121.98%580.29K | 284.07%2.15M | -338.55%-724.63K | -1,087.32%-1.37M | 26.79%-464.14K | 282.94%261.42K | -150.37%-1.17M |
-Change in prepaid assets | 59.89%-55.78K | -313.60%-161.38K | -235.49%-111.16K | -77.48%14.95K | 51.04%51.97K | -125.04%-139.06K | -190.69%-39.02K | 298.85%82.04K | 587.36%66.4K | 28.57%34.41K |
-Change in payables and accrued expense | 2,365.91%738.73K | -138.55%-75.12K | 1,374.95%121.92K | -3.46%-53.92K | -89.10%13.6K | 41.88%-32.6K | 846.66%194.85K | 85.51%-9.56K | -466.94%-52.12K | 372.81%124.74K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -204.08%-1.19M | -83.27%-602.77K | 123.24%3.87M | -62.10%707.4K | 1,177.12%2.35M | 1,558.73%1.14M | -300.57%-328.9K | 178.10%1.73M | 1,699.37%1.87M | 62.04%-218.03K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 16.04%-57.5K | -20,100.00%-1M | -17.24%-88.7K | 106.21%27.94K | -179.73%-53.15K | -584.86%-68.49K | -98.43%5K | 77.54%-75.65K | -675.52%-449.89K | 300.51%66.66K |
Net PPE purchase and sale | ---- | ---- | 18.73%-48.36K | 105.25%23.28K | -104.72%-3.15K | ---- | ---- | 82.34%-59.5K | -667.65%-443.74K | 300.51%66.66K |
Net investment purchase and sale | --0 | ---1M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | -149.74%-40.34K | 175.72%4.66K | ---50K | --0 | --5K | ---16.15K | ---6.15K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 16.04%-57.5K | -20,100.00%-1M | -17.24%-88.7K | 106.21%27.94K | -179.73%-53.15K | -584.86%-68.49K | -98.43%5K | 77.54%-75.65K | -675.52%-449.89K | 300.51%66.66K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,750.30%1.16M | -101.98%-38.26K | 104.66%78.24K | -61.27%-1.91M | 98.67%-6.06K | 434.49%62.52K | 10,449.19%1.93M | -163.38%-1.68M | -883.11%-1.19M | -2,295.49%-455.48K |
Net issuance payments of debt | 58.15%-6.06K | 76.36%-6.06K | -3.48%-1.57M | -37.48%-1.52M | 98.37%-6.06K | 12.44%-14.48K | -37.14%-25.63K | -2,127.24%-1.51M | -237.68%-1.11M | -2,080.82%-372.79K |
Net common stock issuance | --1.16M | --0 | 263.50%2M | -98.18%10K | --0 | --0 | --1.99M | -77.90%550.2K | 12.29%550.2K | --0 |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | ---- | ---- | --210K | --130K | --0 | ---- | ---- | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | --0 | -7.33%-32.2K | 17.98%-565.06K | 11.93%-532.06K | --0 | -39.34%-3K | ---30K | -4,631.47%-688.95K | -5,382.92%-604.11K | -4,206.72%-82.69K |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---25.98K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,750.30%1.16M | -101.98%-38.26K | 104.66%78.24K | -61.27%-1.91M | 98.67%-6.06K | 434.49%62.52K | 10,449.19%1.93M | -163.38%-1.68M | -883.11%-1.19M | -2,295.49%-455.48K |
Net cash flow | ||||||||||
Beginning cash position | 24.29%3.12M | 430.95%4.76M | -2.24%895.77K | 791.96%5.93M | 186.48%3.64M | 81.72%2.51M | -2.24%895.77K | 11.10%916.29K | -17.20%665.21K | -7.83%1.27M |
Current changes in cash | -108.02%-91.22K | -201.90%-1.64M | 18,919.93%3.86M | -610.59%-1.18M | 477.23%2.29M | 1,162.40%1.14M | 247.93%1.61M | -122.40%-20.51K | 104.20%230.57K | -5.21%-606.85K |
End cash Position | -17.02%3.02M | 24.29%3.12M | 430.95%4.76M | 430.95%4.76M | 791.96%5.93M | 186.48%3.64M | 81.72%2.51M | -2.24%895.77K | -2.24%895.77K | -17.20%665.21K |
Free cash from | -213.73%-1.22M | -83.27%-602.77K | 128.28%3.82M | -60.85%730.67K | 1,175.68%2.35M | 1,471.39%1.08M | -414.78%-328.9K | 161.09%1.67M | 1,040.76%1.87M | 62.53%-218.03K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data